Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: Special emphasis on the distinct immunophenotype of the well-differentiated component

International Journal of Surgical Pathology

Volumn 9, Issue 2, 2001, Pages 99-109

  Adachi, Toshisada ^a   Oda, Yoshinao ^a   Sakamoto, Akio ^a   Saito, Tsuyoshi ^a   Tamiya, Sadafumi ^a   Masuda, Kouji ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Dedifferentiated liposarcoma; Immunohistochemistry; mdm2; p21WAF1 CIP1 SDII; p53; Well differentiated liposarcoma

Indexed keywords

PROTEIN MDM2; PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; LABELING INDEX; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOFT TISSUE TUMOR; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

EID: 0034931191     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690100900203     Document Type: Article

References (31)

1. Liposarcoma: A study of 55 cases with a reassessment of its classification
2. Liposarcoma
3. Heterologous elements in the dedifferentiated component of dedifferentiated liposarcoma
4. Dedifferentiated liposarcoma: A clinicopathologic analysis of 155 cases with a proposal for an expanded definition of dedifferentiation
5. p53-mutations in human cancers
6. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
7. The p53 tumour suppressor gene
8. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53
9. Degradation of nuclear oncoproteins by the ubiquitin system in vitro
10. Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas
11. Overexpression and mutation of p53 in endometrial carcinoma
12. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas
13. p53 mutation and MDM2 amplification in human soft tissue sarcomas
14. mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations
15. The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein
16. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma
17. MDM2 gene amplification in bone and soft-tissue tumors: Association with tumor progression in differentiated adipose-tissue tumors
18. Well-differentiated liposarcoma of the retroperitoneum: A clinicopathologic analysis of 20 cases, with particular attention to the extent of low-grade dedifferentiation
19. Lipomatous tumors of the soft tissues: An update
20. Correlation between clinicopathological features and karyotype in lipomatous tumors
21. Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors
22. Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors
23. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors
24. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas
25. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours
26. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: Implications for different pathogenetic mechanisms
27. Biochemical uncovering of mdm2/p53 complexes in liposarcomas parallels their immunohistochemical detection
28. Dedifferentiated liposarcoma of retroperitoneum and mesentery: Varied growth patterns and histological grades - A clinicopathologic study of 32 cases
29. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: Prognostic significance of p21/WAF1/CIP1 expression
30. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: Correlations with proliferation markers, p53 expression and survival
31. Aberrant p21 (CIP1/WAF1) protein accumulation in head-and-neck cancer